Litao Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Litao Hu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Zhen Kang
The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China
3 shared publications - Guocheng Du
Science Center for Future Foods Jiangnan University Wuxi China
2 shared publications - Jian Chen
Science Center for Future Foods, Jiangnan University, Wuxi 214122, China
2 shared publications Sen Xiao
Institute of Future Food Technology, JITRI
2 shared publicationsFaying Wang
The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China
1 shared publicationGuobin Yin
The Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (7) , e0078626
Condensate-based sequestration enables high-efficiency synthesis of mussel foot protein Mcofp-3
Mussel foot proteins (Mfps) hold immense potential for medicine and bioengineering, owing to their exceptional adhesion and biocompatibility. However, traditional extraction from mussels is low-yield and ecologically unsustainable. While microbial synthesis offers a green alternative, the intrinsic hydrophobicity and adhesiveness of Mfps often induce severe host cytotoxicity, resulting in low yields. Initially, attempts to express Mcofp-3 in Escherichia coli were limited to 60 mg L −1 due to such cytotoxic effects. To overcome this bottleneck, we developed a hyaluronic acid (HA)-driven “condensate-based sequestration” strategy. This approach leverages electrostatic interactions to sequester Mcofp-3 into condensates, thereby shielding the host cells and alleviating metabolic stress. This strategy significantly restored cell viability, increasing the titer to 460 mg L −1 in shake flasks. Moreover, the process was successfully scaled up to a 50 L fed-batch fermentation, achieving a final titer of 1.6 g L −1 . Following production, in vitro 3,4-dihydroxyphenylalanine (DOPA) modification was performed using immobilized TyrVs-CipA, yielding functional Mcofp-3 that exhibited anti-inflammatory activity and enhanced cell migration capabilities. This work establishes a versatile, green paradigm for the high-yield production of proteins with low yields and increased toxicity in bacterial expression systems. IMPORTANCE: Mussel foot proteins (Mfps) are prized bio-adhesives for medical applications, yet their supply remains limited. Harvesting mussels is environmentally unsustainable, while microbial synthesis is challenging due to the severe toxicity of these proteins to host cells. In this study, we developed a “condensate-based sequestration” strategy to overcome this bottleneck. By employing hyaluronic acid to isolate the toxic proteins within the bacteria, we shielded the host cells and achieved high-yield production. This approach enabled the gram-scale synthesis of modified Mfps with desirable bioactivity. Beyond synthesizing Mfps, this strategy establishes a versatile, green platform for manufacturing a wide range of other “difficult-to-express” toxic proteins that are currently commercially unviable.
- 4 June 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (7) , e0078626
Open AccessCondensate-based sequestration enables high-efficiency synthesis of mussel foot protein Mcofp-3
Mussel foot proteins (Mfps) hold immense potential for medicine and bioengineering, owing to their exceptional adhesion and biocompatibility. However, traditional extraction from mussels is low-yield and ecologically unsustainable. While microbial synthesis offers a green alternative, the intrinsic hydrophobicity and adhesiveness of Mfps often induce severe host cytotoxicity, resulting in low yields. Initially, attempts to express Mcofp-3 in Escherichia coli were limited to 60 mg L −1 due to such cytotoxic effects. To overcome this bottleneck, we developed a hyaluronic acid (HA)-driven “condensate-based sequestration” strategy. This approach leverages electrostatic interactions to sequester Mcofp-3 into condensates, thereby shielding the host cells and alleviating metabolic stress. This strategy significantly restored cell viability, increasing the titer to 460 mg L −1 in shake flasks. Moreover, the process was successfully scaled up to a 50 L fed-batch fermentation, achieving a final titer of 1.6 g L −1 . Following production, in vitro 3,4-dihydroxyphenylalanine (DOPA) modification was performed using immobilized TyrVs-CipA, yielding functional Mcofp-3 that exhibited anti-inflammatory activity and enhanced cell migration capabilities. This work establishes a versatile, green paradigm for the high-yield production of proteins with low yields and increased toxicity in bacterial expression systems. IMPORTANCE: Mussel foot proteins (Mfps) are prized bio-adhesives for medical applications, yet their supply remains limited. Harvesting mussels is environmentally unsustainable, while microbial synthesis is challenging due to the severe toxicity of these proteins to host cells. In this study, we developed a “condensate-based sequestration” strategy to overcome this bottleneck. By employing hyaluronic acid to isolate the toxic proteins within the bacteria, we shielded the host cells and achieved high-yield production. This approach enabled the gram-scale synthesis of modified Mfps with desirable bioactivity. Beyond synthesizing Mfps, this strategy establishes a versatile, green platform for manufacturing a wide range of other “difficult-to-express” toxic proteins that are currently commercially unviable.
- Open Access
- 28 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Regulating cellular metabolism and morphology to achieve high-yield synthesis of hyaluronan with controllable molecular weights
High-yield biosynthesis of hyaluronan (HA) with controllable molecular weights (MWs) remains challenging due to the poorly understood function of Class I HA synthase (HAS) and the metabolic imbalance between HA biosynthesis and cellular growth. Here, we systematically characterize HAS to identify crucial regions involved in HA polymerization, secretion, and MW control. We construct HAS mutants that achieve complete HA secretion and expand the MW range from 300 to 1400 kDa. By dynamically regulating UDP-glucose 6-dehydrogenase activity and applying an adaptive evolution approach, we recover cell normal growth with increased metabolic capacities. Final titers and productivities for high MW HA (500 kDa) and low MW HA (10 kDa) reach 45 g L−1 and 105 g L−1, 0.94 g L−1 h−1 and 1.46 g L−1 h−1, respectively. Our findings advance our understanding of HAS function and the interplay between cell metabolism and morphology, and provide a shape-guided engineering strategy to optimize microbial cell factories.
- 28 February 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessRegulating cellular metabolism and morphology to achieve high-yield synthesis of hyaluronan with controllable molecular weights
High-yield biosynthesis of hyaluronan (HA) with controllable molecular weights (MWs) remains challenging due to the poorly understood function of Class I HA synthase (HAS) and the metabolic imbalance between HA biosynthesis and cellular growth. Here, we systematically characterize HAS to identify crucial regions involved in HA polymerization, secretion, and MW control. We construct HAS mutants that achieve complete HA secretion and expand the MW range from 300 to 1400 kDa. By dynamically regulating UDP-glucose 6-dehydrogenase activity and applying an adaptive evolution approach, we recover cell normal growth with increased metabolic capacities. Final titers and productivities for high MW HA (500 kDa) and low MW HA (10 kDa) reach 45 g L−1 and 105 g L−1, 0.94 g L−1 h−1 and 1.46 g L−1 h−1, respectively. Our findings advance our understanding of HAS function and the interplay between cell metabolism and morphology, and provide a shape-guided engineering strategy to optimize microbial cell factories.
- Open Access
- 19 June 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Eliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum
Hyaluronan is widely used in cosmetics and pharmaceutics. Development of robust and safe cell factories and cultivation approaches to efficiently produce hyaluronan is of many interests. Here, we describe the metabolic engineering of Corynebacterium glutamicum and application of a fermentation strategy to manufacture hyaluronan with different molecular weights. C. glutamicum is engineered by combinatorial overexpression of type I hyaluronan synthase, enzymes of intermediate metabolic pathways and attenuation of extracellular polysaccharide biosynthesis. The engineered strain produces 34.2 g L−1 hyaluronan in fed-batch cultures. We find secreted hyaluronan encapsulates C. glutamicum, changes its cell morphology and inhibits metabolism. Disruption of the encapsulation with leech hyaluronidase restores metabolism and leads to hyper hyaluronan productions of 74.1 g L−1. Meanwhile, the molecular weight of hyaluronan is also highly tunable. These results demonstrate combinatorial optimization of cell factories and the extracellular environment is efficacious and likely applicable for the production of other biopolymers.
- 19 June 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Open AccessEliminating the capsule-like layer to promote glucose uptake for hyaluronan production by engineered Corynebacterium glutamicum
Hyaluronan is widely used in cosmetics and pharmaceutics. Development of robust and safe cell factories and cultivation approaches to efficiently produce hyaluronan is of many interests. Here, we describe the metabolic engineering of Corynebacterium glutamicum and application of a fermentation strategy to manufacture hyaluronan with different molecular weights. C. glutamicum is engineered by combinatorial overexpression of type I hyaluronan synthase, enzymes of intermediate metabolic pathways and attenuation of extracellular polysaccharide biosynthesis. The engineered strain produces 34.2 g L−1 hyaluronan in fed-batch cultures. We find secreted hyaluronan encapsulates C. glutamicum, changes its cell morphology and inhibits metabolism. Disruption of the encapsulation with leech hyaluronidase restores metabolism and leads to hyper hyaluronan productions of 74.1 g L−1. Meanwhile, the molecular weight of hyaluronan is also highly tunable. These results demonstrate combinatorial optimization of cell factories and the extracellular environment is efficacious and likely applicable for the production of other biopolymers.